Coupling S100A4 to Rhotekin alters Rho signaling output in breast cancer cells

49Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Rho signaling is increasingly recognized to contribute to invasion and metastasis. In this study, we discovered that metastasis-associated protein S100A4 interacts with the Rho-binding domain (RBD) of Rhotekin, thus connecting S100A4 to the Rho pathway. Glutathione S-transferase pull-down and immunoprecipitation assays demonstrated that S100A4 specifically and directly binds to Rhotekin RBD, but not the other Rho effector RBDs. S100A4 binding to Rhotekin is calcium-dependent and uses residues distinct from those bound by active Rho. Interestingly, we found that S100A4 and Rhotekin can form a complex with active RhoA. Using RNA interference, we determined that suppression of both S100A4 and Rhotekin leads to loss of Rho-dependent membrane ruffling in response to epidermal growth factor, an increase in contractile F-actin 'stress' fibers and blocks invasive growth in three-dimensional culture. Accordingly, our data suggest that interaction of S100A4 and Rhotekin permits S100A4 to complex with RhoA and switch Rho function from stress fiber formation to membrane ruffling to confer an invasive phenotype. © 2013 Macmillan Publishers Limited.

Cite

CITATION STYLE

APA

Chen, M., Bresnick, A. R., & O’Connor, K. L. (2013). Coupling S100A4 to Rhotekin alters Rho signaling output in breast cancer cells. Oncogene, 32(32), 3754–3764. https://doi.org/10.1038/onc.2012.383

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free